HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamides-Reference-Cited by-同舟云学术

HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamides

Published:2012-10 Issue:19 Volume:22 Page:6063-6066
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

St. Laurent Denis R.,Belema Makonen,Gao Min,Goodrich Jason,Kakarla Ramesh,Knipe Jay O.,Lemm Julie A.,Liu Mengping,Lopez Omar D.,Nguyen Van N.,Nower Peter T.,O’Boyle Donald,Qiu Yuping,Romine Jeffrey L.,Serrano-Wu Michael H.,Sun Jin-Hua,Valera Lourdes,Yang Fukang,Yang Xuejie,Meanwell Nicholas A.,Snyder Lawrence B.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference25 articles.

1. Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes

2. Peginterferon and Ribavirin for Chronic Hepatitis C

3. Evolving epidemiology of hepatitis C virus

4. Current drug discovery strategies for treatment of hepatitis C virus infection

5. Promising Targets for Anti-Hepatitis C Virus Agents

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pseudoprolines as stereoelectronically tunable proline isosteres;Bioorganic & Medicinal Chemistry Letters;2022-11

2. A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus;European Journal of Medicinal Chemistry;2019-04

3. Why highly effective drugs are not enough: the need for an affordable solution to eliminating HCV;Expert Review of Clinical Pharmacology;2017-04-10

4. Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection;Comprehensive Medicinal Chemistry III;2017

5. New potent biaryl sulfate-based hepatitis C virus inhibitors;European Journal of Medicinal Chemistry;2017-01